Document is current
Any future updates will be listed below
-
Authors
Xu, Yang https://orcid.org/0000-0003-4173-4337
Kramann, Rafael
McCord, Rachel Patton https://orcid.org/0000-0003-0010-5323
Hayat, Sikander https://orcid.org/0000-0001-5919-8371
-
Funding
Funding for this research was provided by:
Fondation Leducq (Leducq early career investigator grant)
Novo Nordisk
- License Information
-
More Information
Article History
Received: 5 December 2022
Accepted: 6 April 2023
First Online: 28 April 2023
Competing interests
: The authors do not have competing interests in this topic. Disclosures: S.H. has received funding from Novo Nordisk, R.K. has received grants from Travere Therapeutics, Galapagos, Chugai, and Novo Nordisk and is a consultant or received honoraria from Bayer, Pfizer, Novo Nordisk, Lilly-Pharma and Grünenthal.
